REGINALD GARRETT
Professor of Biology
 
E
Email:    rhg@virginia.edu
Office:    (434) 982-5494
Lab:       (434) 243-5492
Office:    229 Chemistry Building
           
E
EDUCATION
B.S., The Johns Hopkins University, 1964
Ph.D., The Johns Hopkins University, 1964
  Postdoctoral Research, The Johns Hopkins University, 1968
   
         
  RESEARCH INTERESTS  
  Together with my colleague, Mitchell Smith of the Center for Food Safety and Applied Nutrition (CFSAN) in the Food and Drug Administration (FDA), we have taken a systems analysis approach to discover the relationship between a number of inflammatory disease conditions and the consumption of various drugs and/or dietary supplements. A prominent example is eosinophilia-myalgia syndrome ( EMS ) and the consumption of L-tryptophan-containing dietary supplements (LTCDS). The belief that microimpurities found in mass-produced
 

LTCDS caused EMS in individuals consuming such supplements remains widespread in the epidemiological, medical, and nutritional communities, even though no impurity with such toxicity has ever been identified. At least three dozen deaths are attributed to EMS and the ingestion of LTCDS. Our systems analysis of EMS based on Boolean-logic, keyword-based computer searches of peer-reviewed literature disclosed correlations between eosinophilia (elevated circulating eosinophil levels), myalgia (muscle pain), and compromised histamine degradation. Both eosinophilia and myalgia are conditions associated with excessive histamine activity. Our search revealed that consumption of tryptophan supplements leads to enhanced levels of formate and indolyl compounds, several of which impair histamine degradation and thus have the potential to prolong the latent effect of histamine. In light of our findings, the assumption that microimpurities in LTCDS cause EMS is unwarranted.

         
  REPRESENTATIVE PUBLICATIONS  
 

Smith, M. J., and Garrett, R. H. "A heretofore undisclosed crux of eosinophilia-myalgia syndrome: Compromised histamine degradation." Inflammation Research 54 : 435-450 (2005).

     
 

Smith, M. J., and Garrett, R. H. "Part II. Eosinophilia-Myalgia Syndrome: correlations between compromised histamine degradation, eosinophilias and myopathies." Inflammation Research 56 : S08-S09 (2007).

         
 

Smith, M. J., and Garrett, R. H. "Part III. Keyword-based, Boolean-logic driven data-mining discloses correlations between additional idiopathic conditions, occlusive vascular diseases such as tropical endomyocardial fibrosis with unexplained eosinophilia, and 'histamine dysmetabolism'. Inflammation Research 57 : S01-S02 (2008).

         

 

© Copyright 2008-10